Trinity Biotech PLC SEC filings TRIB
Trinity Biotech PLC has 500 filings in SEC EDGAR's recent list, going back to Sep 9, 1996. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| POS AM | Filing | Aug 28, 2026 | — |
| F-1/A | Form f-1/a | Aug 21, 2026 | — |
| 424B3 | Prospectus | Jun 23, 2026 | — |
| 424B3 | Prospectus | Jun 18, 2026 | — |
| 424B3 | Prospectus | Jun 15, 2026 | — |
| 424B5 | Prospectus supplement | Jun 12, 2026 | — |
| POS AM | Filing | Jun 4, 2026 | — |
| F-1/A | Form f-1/a | Jun 3, 2026 | — |
| 424B3 | Prospectus | May 26, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | May 13, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | May 13, 2026 | — |
| 424B3 | Prospectus | Mar 10, 2026 | — |
| 424B3 | Prospectus | Mar 10, 2026 | — |
| 424B3 | Prospectus | Mar 4, 2026 | — |
| 424B3 | Prospectus | Feb 25, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Feb 25, 2026 | — |
| 424B3 | Prospectus | Feb 17, 2026 | — |
| 424B3 | Prospectus | Jan 23, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Jan 15, 2026 | — |
| 424B3 | Prospectus | Mar 31, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 21, 2025 | — |
| 424B5 | Prospectus supplement | Dec 27, 2024 | — |
| 424B5 | Prospectus supplement | Dec 17, 2024 | — |
| 424B3 | Prospectus | Dec 5, 2024 | — |
| F-3/A | Filing | Nov 29, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 15, 2024 | — |
| 424B5 | Prospectus supplement | Sep 20, 2024 | — |
| 424B5 | Prospectus supplement | Aug 28, 2024 | — |
| 424B5 | Prospectus supplement | Jul 12, 2024 | — |
| F-3/A | Filing | Jun 28, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 21, 2024 | — |
| 424B3 | Prospectus | May 7, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 30, 2024 | — |
| 424B3 | Prospectus | Feb 15, 2024 | — |
| 424B3 | Prospectus | Mar 31, 2023 | — |
| POS AM | Filing | Mar 23, 2023 | — |
| 424B3 | Prospectus | Sep 15, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 30, 2022 | — |
| 424B3 | Prospectus | May 26, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | May 16, 2022 | — |
| S-8 | Employee stock plan registration | Feb 12, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 6, 2020 | — |
| F-3/A | Filing | Apr 26, 2017 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 22, 2015 | — |
| S-8 | Employee stock plan registration | Apr 11, 2014 | — |
| S-8 | Employee stock plan registration | Jun 22, 2012 | — |
| S-8 POS | Filing | Apr 15, 2011 | — |
| S-8 POS | Filing | Apr 15, 2011 | — |
| S-8 | Employee stock plan registration | May 6, 2010 | — |
| S-8 POS | Post-effective amendment no. 2 to form s-8 | Sep 21, 2009 | — |
| 424B5 | Prospectus supplement | Apr 8, 2008 | — |
| 424B5 | Prospectus supplement | Apr 6, 2006 | — |
| 424B5 | Prospectus supplement | Apr 6, 2006 | — |
| 424B3 | Prospectus | Apr 6, 2006 | — |
| 424B3 | Prospectus | Jun 7, 2005 | — |
| F-3/A | Amend. no. 1 to form f-3 | May 16, 2005 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 28, 2005 | — |
| S-8 | Employee stock plan registration | Apr 28, 2005 | — |
| 424B1 | Filing | Jun 25, 2004 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 16, 2004 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 31, 2004 | — |
| F-3MEF | Registration statement | Feb 25, 2004 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 6, 2004 | — |
| F-3/A | Amendment no. 2 | Dec 10, 2003 | — |
| F-3/A | Amendment no.1 | Sep 12, 2003 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 25, 2003 | — |
| S-3 | Shelf registration | Jul 25, 2003 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 7, 2003 | — |
Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- TRIB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Ireland
- Headquarters
- Wicklow
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 888721
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.